SUSQUEHANNA INTERNATIONAL GROUP, LLP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 118 filers reported holding VIKING THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,508,273
-60.5%
1,400,928
-42.1%
0.00%
-62.5%
Q2 2023$39,235,997
-5.2%
2,420,481
-2.6%
0.01%
-11.1%
Q1 2023$41,370,388
+266.9%
2,484,708
+107.1%
0.01%
+200.0%
Q4 2022$11,276,785
+577.7%
1,199,658
+96.1%
0.00%
Q3 2022$1,664,000
+144.7%
611,639
+160.1%
0.00%
Q2 2022$680,000
-31.7%
235,197
-29.1%
0.00%
Q1 2022$996,000
-74.3%
331,834
-60.6%
0.00%
Q4 2021$3,870,000
+0.7%
841,404
+37.5%
0.00%
Q3 2021$3,842,000
+26.9%
611,865
+21.1%
0.00%
Q2 2021$3,027,000
-29.0%
505,458
-25.0%
0.00%
Q1 2021$4,263,000
-37.3%
673,834
-44.3%
0.00%
Q4 2020$6,804,000
+57.5%
1,208,708
+62.9%
0.00%
Q3 2020$4,319,000
-19.0%
742,072
+0.3%
0.00%
-100.0%
Q2 2020$5,335,000
+89.3%
739,801
+22.8%
0.00%
Q1 2020$2,819,000
-61.8%
602,295
-34.6%
0.00%
-100.0%
Q4 2019$7,381,000
-24.6%
920,300
-35.3%
0.00%
-50.0%
Q3 2019$9,788,000
-78.3%
1,422,766
-73.8%
0.00%
-20.0%
Q2 2019$45,074,000
+141.9%
5,430,845
+189.7%
0.01%
-28.6%
Q1 2019$18,636,000
+662.8%
1,874,900
+487.0%
0.01%
Q4 2018$2,443,000
-81.0%
319,422
-56.8%
0.00%
-100.0%
Q3 2018$12,872,000
+183.7%
738,900
+54.5%
0.00%
+300.0%
Q2 2018$4,537,000
+114.4%
478,100
-1.3%
0.00%
Q1 2018$2,116,000
+2059.2%
484,187
+844.8%
0.00%
Q3 2017$98,00051,2470.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders